Benzinga | Aug 6, 2020 07:11AM EDT

SVB Leerink Maintains Outperform on Axcella Health, Lowers Price Target to $10

SVB Leerink maintains Axcella Health (NASDAQ:AXLA) with a Outperform and lowers the price target from $20 to $10.